Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Tigecycline for Treatment of Serious Infection Due to Rapidly Growing Mycobacteria (Especially M.Abscessus)

NCT00600600 is registered in ClinicalTrials.gov with The University of Texas Health Science Center at Tyler as lead sponsor.

NCT NCT00600600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00600600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Tigecycline for Treatment of Serious Infection Due to Rapidly Growing Mycobacteria (Especially M.Abscessus)
Lead sponsor
The University of Texas Health Science Center at Tyler
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2002
Completion date
December 31, 2010
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mycobacterium abscessus lung disease, rapidly growing mycobacterial lung disease